<DOC>
	<DOCNO>NCT02208674</DOCNO>
	<brief_summary>Chronic kidney disease ( CKD ) highly prevalent associate significantly increase risk cardiovascular morbidity end-stage renal disease . Evidence randomize clinical trial suggest treat urinary albumin excretion ( UAE ) , dyslipidemia , hypertension reduce risk . Unfortunately , less 30 % CKD population screen treat accord recommend guideline . Using cluster-randomized , controlled design clinic-embedded pharmacist , pilot pragmatic trial randomize 6 Geisinger primary care clinic ( 72 patient ) usual care ( group 1 ) pharmacist-directed `` CKD Action Plan '' ( group 2 ) . Determining impact CKD Action Plan screen treatment guideline adherence primary goal pilot study .</brief_summary>
	<brief_title>Early Identification Action CKD</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>18 year age old eGFRCR value 4559 ml/min/1.73m2 prior 12 month schedule laboratory appointment serum creatinine test within next 30 day average systolic diastolic blood pressure read least 150 85 mm Hg , respectively , prior 12 month . few 2 blood pressure read prior 12 month , pregnancy current hospitalization life expectancy le 6 month determine study investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>chronic kidney disease</keyword>
	<keyword>albuminuria</keyword>
	<keyword>hypertension</keyword>
	<keyword>dyslipidemia</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>pragmatic trial</keyword>
	<keyword>cluster randomize trial</keyword>
</DOC>